Dynamic Technology Lab Private LTD Voyager Therapeutics, Inc. Transaction History

Dynamic Technology Lab Private LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$4.82 - $10.09 $71,403 - $149,473	14,814 New	14,814 $88,000
Q2 2020 Aug 14, 2020	SELL	$8.05 - $14.21 $308,508 - $544,584	-38,324 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$6.8 - $14.66 $260,603 - $561,829	38,324 New	38,324 $351,000
Q3 2019 Nov 14, 2019	SELL	$16.31 - $28.29 $209,746 - $363,809	-12,860 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$19.18 - $27.88 $246,654 - $358,536	12,860 New	12,860 $350,000
Q3 2018 Nov 14, 2018	SELL	$17.11 - $21.74 $180,955 - $229,922	-10,576 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$16.76 - $23.92 $78,386 - $111,873	-4,677 Reduced 30.66%	10,576 $207,000
Q1 2018 Jun 14, 2018	SELL	$16.16 - $31.31 $147,880 - $286,517	-9,151 Reduced 37.5%	15,253 $287,000
Q1 2018 May 14, 2018	BUY	$16.16 - $31.31 $214,071 - $414,763	13,247 Added 118.73%	24,404 $459,000
Q4 2017 Feb 09, 2018	BUY	$12.26 - $25.88 $136,784 - $288,743	11,157	11,157 $185,000

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $223M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.